Thursday, October 30th8.7°C
23888
23371

J&J receives $4.15 billion offer for Ortho-Clinical Diagnostics business from Carlyle Group

TRENTON, N.J. - Johnson & Johnson said Thursday that it's been offered $4.15 billion by The Carlyle Group for its Ortho-Clinical Diagnostics business, a year after J&J began reviewing strategic options for the blood-testing unit as part of a routine pruning of its extensive family of businesses.

J&J, based in New Brunswick, N.J., has until March 31 to decide whether to accept the offer. Johnson & Johnson executives plan to discuss the offer Tuesday, when the health giant and consumer products company reports fourth-quarter results. The company said Thursday that it will consult with works councils and trade unions representing the unit's employees before making a decision.

The Ortho-Clinical business serves hospitals, testing laboratories and blood banks.

One division supplies equipment and chemicals to screen donated blood for HIV, hepatitis C and other serious diseases, and for typing donated blood to ensure patients get safe, compatible blood transfusions. The other division makes technology for advanced testing of blood to diagnose a range of health conditions and to monitor the effects of medication.

Established in 1937, Ortho Clinical Diagnostics is based in Raritan, N.J., and has factories in Rochester, N.Y.; Pompano Beach, Fla., and Pencoed, Wales. It has more than 4,500 employees and operates in more than 30 countries worldwide.

Last January, CEO Alex Gorsky said J&J was looking at strategic options for Ortho-Clinical Diagnostics, which doesn't meet the company's long-held strategy of focusing on businesses that rank first or second in their markets.

In 2012, J&J reported revenue of $2.1 billion for the diagnostics business, down more than 4 per cent from 2011. Revenue fell even more over the first nine months of 2013, when it was down 8 per cent from the prior year at $1.42 billion.

Carlyle Group is a private equity and buyout firm based in Washington, D.C. If the sale goes through, Carlyle is expected to try to expand the business through increased marketing and creation of new products. Carlyle manages more than $185 billion worth of assets worldwide, according to its website.

In afternooon trading, Carlyle shares were up 1 cent at $37. Johnson & Johnson shares were down 25 cents at $94.55. The stock has seen a tremendous run-up since Gorsky took over in April 2012, with shares rising 46 per cent from $64.75 back then.

___

AP Business Writer Tom Murphy in Indianapolis contributed to this report.

The Canadian Press


Read more Business News




Recent Trending




Today's Market
S&P TSX14458.69-68.88
S&P CDNX771.65-9.42
DJIA17195.42221.11
Nasdaq4566.138+16.912
S&P 5001994.65+12.35
CDN Dollar0.8923-0.0011
Gold1193.40-5.20
Oil80.63-0.27
Lumber322.40-1.20
Natural Gas3.715+0.066

 
Okanagan Companies
Pacific Safety0.11+0.01
Knighthawk0.01-0.005
QHR Technologies Inc1.150.00
Cantex0.045-0.015
Anavex Life Sciences0.1711-0.0089
Metalex Ventures0.0350.00
Russel Metals32.22-0.35
Copper Mountain Mining1.97-0.05
Colorado Resources0.14+0.005
ReliaBrand Inc0.012-0.004
Sunrise Resources Ltd0.05+0.025
Mission Ready Services0.375+0.005

 





FEATURED Property
18315585351 Ptarmigan Street, Kelowna, BC
5 bedrooms 4 baths
$684,000
more details
image2image2image2
Click here to feature your property
Please wait... loading


Empty nesting: financial issues

Now that the children have ‘left the nest’, it is a good time to step back and take stock of your financial situation. Being on your own will probably cut household costs to some extent, b...


Keep your haunted home safe

Eerie sounds, spooky lights and Jack-o’-lanterns aglow—extra efforts at Halloween will keep visitors coming back for both tricks and treats. However, to keep the fun going, it’s imp...


What I learned in China

Photo: ContributedI will never be an expert on China. It is just too big, too complex and too old with layers of history and meaning that would take several lifetimes to unravel. As I said to my hosts...

_








Member of BC Press Council


23741